US Licensing Strategy of Small and Mid-Sized European Pharmaceutical Companies
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 27 (Table of Contents)
Published: 2 Aug-2002
DOI: 10.3833/pdr.v2002.i27.1022 ISSN: 1756-7874
Section: General
Abstract
Small and Mid-Sized European Companies (SMECs) has produced significant new blockbuster drugs that have been launched in Europe or progressed into late-stage development...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Last Issue PDF
RSS